14592

532843

FORTIS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

FORTIS HEALTHCARE LTD Share Price Today

FORTIS HEALTHCARE LTD is currently trading at ₹961.05, up by ₹2.29 from the previous close. The stock touched an intraday high of ₹964.45 and a low of ₹953.10 during the latest trading session. Over the past one year, FORTIS HEALTHCARE LTD has delivered a return of 24.69%, while the stock has declined 1.29% in the last one month.

FORTIS HEALTHCARE LTD performance

Today’s low Today’s high
₹ 953.10 ₹ 964.45
₹ 962.55
52 week low 52 week high
₹ 743.65 ₹ 1104.30
₹ 962.55
Open Price ₹ 958.75
Prev. Close ₹ 958.75
Volume (Shares) 262329.00
Total traded value ₹ 2525.04
Upper Circuit ₹ 1054.60
Lower Circuit ₹ 862.90
info

Investment Returns

Over 1 Month -1.29% Over 3 Months 15.78% Over 6 Months 9.03% Over 1 Year 24.69%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

FORTIS HEALTHCARE LTD fundamentals


  • Market cap (Cr) 72,400.50
  • P/E Ratio (TTM) 314.36
  • Beta 0.83
  • Book Value / share 122.24
  • Return on equity 1.41%
  • EPS (TTM) 2.70
  • Dividend yield 0.10%
  • Net profit/quarter (Cr) 24.98
info icon alternate text
  • Market cap (Cr) 72,744.00
  • P/E Ratio (TTM) 314.36
  • Beta 0.71
  • Book Value / share 122.24
  • Return on equity 1.41%
  • EPS (TTM) 2.70
  • Dividend yield 0.10%
  • Net profit/quarter (Cr) 24.98
info icon alternate text

FORTIS HEALTHCARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 460.73
Operating Expense 427.82
Net Profit 24.98
Net Profit Margin (%) 5.42
Earnings Per Share (EPS) 0.33
EBITDA 114.77
Effective Tax Rate (%) 33.15
Particulars DEC 2025 (Values in Cr)
Revenue 442.93
Operating Expense 429.45
Net Profit 28.40
Net Profit Margin (%) 6.41
Earnings Per Share (EPS) 0.38
EBITDA 119.46
Effective Tax Rate (%) 16.91
Particulars SEP 2025 (Values in Cr)
Revenue 455.81
Operating Expense 435.08
Net Profit 125.09
Net Profit Margin (%) 27.44
Earnings Per Share (EPS) 1.65
EBITDA 214.12
Effective Tax Rate (%) 7.32
Particulars JUN 2025 (Values in Cr)
Revenue 433.03
Operating Expense 426.95
Net Profit 51.88
Net Profit Margin (%) 11.98
Earnings Per Share (EPS) 0.69
EBITDA 145.00
Effective Tax Rate (%) 17.61
Particulars MAR 2025 (Values in Cr)
Revenue 388.47
Operating Expense 399.93
Net Profit -42.23
Net Profit Margin (%) -10.87
Earnings Per Share (EPS) -0.56
EBITDA 43.53
Effective Tax Rate (%) -8.56
Particulars MAR 2026 (Values in Cr)
Revenue 1792.50
Operating Expense 1719.32
Net Profit 230.34
Net Profit Margin (%) 12.85
Earnings Per Share (EPS) 3.05
EBITDA 593.35
Effective Tax Rate (%) 14.52
Particulars MAR 2025 (Values in Cr)
Revenue 1445.89
Operating Expense 1414.87
Net Profit 63.79
Net Profit Margin (%) 4.41
Earnings Per Share (EPS) 0.84
EBITDA 338.92
Effective Tax Rate (%) 44.24
Particulars MAR 2024 (Values in Cr)
Revenue 1181.42
Operating Expense 1171.51
Net Profit 199.45
Net Profit Margin (%) 16.88
Earnings Per Share (EPS) 2.64
EBITDA 429.46
Effective Tax Rate (%) 19.10
Particulars MAR 2023 (Values in Cr)
Revenue 1052.93
Operating Expense 1141.91
Net Profit 96.24
Net Profit Margin (%) 9.14
Earnings Per Share (EPS) 1.27
EBITDA 331.00
Effective Tax Rate (%) 11.60
Particulars MAR 2022 (Values in Cr)
Revenue 862.61
Operating Expense 989.42
Net Profit -13.25
Net Profit Margin (%) -1.53
Earnings Per Share (EPS) -0.18
EBITDA 233.22
Effective Tax Rate (%) -47.38
Particulars MAR 2025 (Values in Cr)
Book Value / Share 118.11
ROE % 9.42
ROCE % 11.28
Total Debt to Total Equity 0.22
EBITDA Margin 19.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 101.50
ROE % 7.81
ROCE % 9.65
Total Debt to Total Equity 0.14
EBITDA Margin 18.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.93
ROE % 6.79
ROCE % 7.51
Total Debt to Total Equity 0.16
EBITDA Margin 17.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 81.84
ROE % 7.45
ROCE % 7.75
Total Debt to Total Equity 0.23
EBITDA Margin 18.83
Particulars MAR 2021 (Values in Cr)
Book Value / Share 81.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin 11.99
Particulars MAR 2025 (Values in Cr)
Book Value / Share 120.19
ROE % 1.41
ROCE % 3.26
Total Debt to Total Equity 0.15
EBITDA Margin 30.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 120.37
ROE % 1.37
ROCE % 2.41
Total Debt to Total Equity 0.08
EBITDA Margin 27.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 118.73
ROE % 0.61
ROCE % 1.69
Total Debt to Total Equity 0.11
EBITDA Margin 25.99
Particulars MAR 2022 (Values in Cr)
Book Value / Share 117.47
ROE % 0.08
ROCE % 1.35
Total Debt to Total Equity 0.14
EBITDA Margin 27.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 117.64
ROE % -0.37
ROCE % 1.06
Total Debt to Total Equity 0.15
EBITDA Margin 33.62
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 507.99
Total Assets 13691.52
Total Liabilities 13691.52
Total Equity 9169.39
Share Outstanding 75
Price to Book Ratio 5.81
Return on Assets (%) 5.65
Return on Capital (%) 6.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 598.39
Total Assets 13288.78
Total Liabilities 13288.78
Total Equity 8556.13
Share Outstanding 75
Price to Book Ratio 3.49
Return on Assets (%) 4.50
Return on Capital (%) 6.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 362.72
Total Assets 12433.60
Total Liabilities 12433.60
Total Equity 8100.38
Share Outstanding 75
Price to Book Ratio 2.19
Return on Assets (%) 4.73
Return on Capital (%) 6.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 412.69
Total Assets 11884.74
Total Liabilities 11884.74
Total Equity 7008.25
Share Outstanding 75
Price to Book Ratio 2.47
Return on Assets (%) 4.67
Return on Capital (%) 6.96
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 416.58
Total Assets 11154.68
Total Liabilities 11154.68
Total Equity 6717.81
Share Outstanding 75
Price to Book Ratio 1.69
Return on Assets (%) -0.98
Return on Capital (%) -1.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 49.45
Total Assets 11999.06
Total Liabilities 11999.06
Total Equity 9074.00
Share Outstanding 75
Price to Book Ratio 5.81
Return on Assets (%) 0.53
Return on Capital (%) 0.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 119.94
Total Assets 10386.91
Total Liabilities 10386.91
Total Equity 9087.16
Share Outstanding 75
Price to Book Ratio 3.49
Return on Assets (%) 1.92
Return on Capital (%) 2.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.03
Total Assets 10368.67
Total Liabilities 10368.67
Total Equity 8963.53
Share Outstanding 75
Price to Book Ratio 2.19
Return on Assets (%) 0.92
Return on Capital (%) 1.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.07
Total Assets 10426.20
Total Liabilities 10426.20
Total Equity 8868.56
Share Outstanding 75
Price to Book Ratio 2.47
Return on Assets (%) -0.12
Return on Capital (%) -0.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.50
Total Assets 10582.14
Total Liabilities 10582.14
Total Equity 8881.53
Share Outstanding 75
Price to Book Ratio 1.69
Return on Assets (%) 0.03
Return on Capital (%) 0.04
Particulars MAR 2025 (Values in Cr)
Net Income 1007.04
Cash from Operations 1533.59
Cash from Investing -779.37
Cash from Financing -713.85
Net change in Cash -69.75
Free Cash Flow 2380.52
Particulars MAR 2024 (Values in Cr)
Net Income 857.96
Cash from Operations 1321.90
Cash from Investing -886.36
Cash from Financing -86.45
Net change in Cash 124.51
Free Cash Flow 2264.37
Particulars MAR 2023 (Values in Cr)
Net Income 813.67
Cash from Operations 1096.47
Cash from Investing -373.69
Cash from Financing -471.22
Net change in Cash -21.43
Free Cash Flow 1557.60
Particulars MAR 2022 (Values in Cr)
Net Income 987.78
Cash from Operations 1076.76
Cash from Investing -514.37
Cash from Financing -517.31
Net change in Cash -166.23
Free Cash Flow 1292.25
Particulars MAR 2021 (Values in Cr)
Net Income 43.29
Cash from Operations 438.03
Cash from Investing -135.09
Cash from Financing -142.92
Net change in Cash 212.01
Free Cash Flow 656.54
Particulars MAR 2025 (Values in Cr)
Net Income 114.41
Cash from Operations 331.99
Cash from Investing -1572.20
Cash from Financing 1275.90
Net change in Cash 37.71
Free Cash Flow 697.19
Particulars MAR 2024 (Values in Cr)
Net Income 246.56
Cash from Operations 241.50
Cash from Investing 44.45
Cash from Financing -245.34
Net change in Cash 17.55
Free Cash Flow 566.13
Particulars MAR 2023 (Values in Cr)
Net Income 108.88
Cash from Operations 232.01
Cash from Investing 204.64
Cash from Financing -395.43
Net change in Cash 7.59
Free Cash Flow 285.66
Particulars MAR 2022 (Values in Cr)
Net Income -8.98
Cash from Operations 125.28
Cash from Investing 237.73
Cash from Financing -319.82
Net change in Cash -5.59
Free Cash Flow 152.10
Particulars MAR 2021 (Values in Cr)
Net Income 24.13
Cash from Operations 41.44
Cash from Investing 28.40
Cash from Financing 5.91
Net change in Cash 66.26
Free Cash Flow 97.77
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 61.98 12.79 121241.38 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 53.09 24.02 2.89 99.50 40.75 76.00
SHREE PACETRONIX LTD. 138.30 16.50 2.91 51.86 66.10 283.15
TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 80.76 12.16 121241.38 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.42 0.00 -9.10 27.95 30.30 57.48
KOVAI MEDICAL CENTER & HO 5844.00 26.15 4.84 6393.34 5010.00 6725.00

FORTIS HEALTHCARE LTD shareholding pattern

Holding
11.5%
31.16%
25.97%
31.35%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

FORTIS HEALTHCARE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
959.00 0.02 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 965.50
  • 26 Days 959.10
  • 10 Days 967.80
  • 50 Days 941.70
  • 12 Days 967.40
  • 100 Days 922.50
  • 20 Days 963.40
  • 200 Days 894.20
955.08 PIVOT
First Support 937.37 First Resistance 967.37 Second Support 925.08 Second Resistance 985.08 Third Support 907.37 Third Resistance 997.37
RSI 46.49 ADX 18.15 MACD 9.79 Williams % R -54.46 Commodity Channel Index (CCI) -32.25
Date 2026-06-17 Week 832171.00 Same Day 1464610.00 Month 770293.00
1 Year 0.83 3 Year 0.67
Over 1 Month
-1.29% down
Over 1 Year
24.69% down
Over 3 Months
15.78% down
Over 3 Years
45.72% down
Over 6 Months
9.03% down
Over 5 Years
32.33% down

FORTIS HEALTHCARE LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Jul 2025 1.0 Final 25 Jul 2025 Equity shares
24 Jul 2024 1.0 Final 24 Jul 2024 Equity shares
20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
25 Jul 2025 1.0 Final 25 Jul 2025 Equity shares
24 Jul 2024 1.0 Final 24 Jul 2024 Equity shares
20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fortis Healthcare Ltd?

Answer Field

Fortis Healthcare Ltd share price is for NSE ₹ 961.05 & for BSE ₹ 960.55 as on Jun 19 2026 10:47 AM.

What is the Market Cap of Fortis Healthcare Ltd Share?

Answer Field

The market cap of Fortis Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 19 2026 10:47 AM.

What is the 52 Week High and Low of Fortis Healthcare Ltd?

Answer Field

The 52 Week High and Low of Fortis Healthcare Ltd for NSE is ₹ 1,104.30 and ₹ 743.65 and for BSE is ₹ 1,105.00 and ₹ 741.45.

What is 1 year return for Fortis Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 26.31%.

What is the P/E Ratio of Fortis Healthcare Ltd Share?

Answer Field

As on Jun 19 2026 10:47 AM the price-to-earnings (PE) ratio for Fortis Healthcare Ltd share is 314.36.

What is the PB ratio of Fortis Healthcare Ltd Share?

Answer Field

As on Jun 19 2026 10:47 AM, the price-to-book (PB) ratio for Fortis Healthcare Ltd share is 122.24.

How to Buy Fortis Healthcare Ltd Share?

Answer Field

You can trade in Fortis Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fortis Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Fortis Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fortis Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|